Evommune, Inc. Common Stock (EVMN)

Operating Expenses

$34.90M

Quarterly · Period ending: · USD

EVMN logo

EVMN Operating Expenses

Latest reported$34.90M
EVMN Quarterly Operating Expenses ($10.48M → $34.90M)
High-resolution chart · PNG

EVMN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
34,895,000
23,954,000
29,716,000
23,328,000
22,619,000
17,655,000
18,985,000
16,517,000
27,964,000
10,483,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.